FDA allows marketing of first-of-kind computerized cognitive tests to help assess cognitive skills after a head injury (FDA news release):
“The U.S. Food and Drug Administration today permitted marketing of two new devices to assess a patient’s cognitive function immediately after a suspected brain injury or concussion. The Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) and ImPACT Pediatric are the first medical devices permitted [Read more…] about The FDA clears two computerized cognitive tests to assist in medical evaluations following brain injury or concussion